Determinants of prostate cancer-specific survival following radiation therapy for patients with clinically localized prostate cancer

被引:0
|
作者
D'Amico, AV [1 ]
机构
[1] Harvard Univ, Sch Med, Joint Ctr Radiat Therapy, Boston, MA 02215 USA
来源
PROSTATE AND RENAL CANCER, BENIGN PROSTATIC HYPERPLASIA, ERECTILE DYSFUNCTION AND BASIC RESEARCH: AND UPDATE | 2003年
关键词
D O I
暂无
中图分类号
R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
摘要
引用
收藏
页码:380 / 389
页数:10
相关论文
共 50 条
  • [31] Rectal endoscopy findings following stereotactic body radiation therapy for clinically localized prostate cancer
    Sumit Sood
    Andrew W Ju
    Honkung Wang
    Siyuan Lei
    Sunghae Uhm
    Guowei Zhang
    Simeng Suy
    John Carroll
    John Lynch
    Anatoly Dritschilo
    Sean P Collins
    Radiation Oncology, 8
  • [32] PSA control following definitive therapy for clinically localized prostate cancer
    D'Amico, A
    MOLECULAR UROLOGY, 1999, 3 (03) : 207 - 211
  • [34] Gastrointestinal toxicities following radiation therapy for localized prostate cancer
    Lu-Yao, G. L.
    Kim, S.
    Moore, D.
    Shih, W.
    Lin, Y.
    Shen, S.
    Li, H.
    Dolan, M.
    Shao, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (07)
  • [35] Rates of Positive Surgical Margins and Their Effect on Cancer-specific Mortality at Radical Prostatectomy for Patients With Clinically Localized Prostate Cancer
    Preisser, Felix
    Mazzone, Elio
    Knipper, Sophie
    Nazzani, Sebastiano
    Bandini, Marco
    Shariat, Shahrokh F.
    Tian, Zhe
    Saad, Fred
    Montorsi, Francesco
    Zorn, Kevin C.
    Graefen, Markus
    Tilki, Derya
    Karakiewicz, Pierre, I
    CLINICAL GENITOURINARY CANCER, 2019, 17 (01) : E130 - E139
  • [37] PROSTATE-SPECIFIC ANTIGEN AS A PRETHERAPY PROGNOSTIC FACTOR IN PATIENTS TREATED WITH RADIATION-THERAPY FOR CLINICALLY LOCALIZED PROSTATE-CANCER
    PISANSKY, TM
    CHA, SS
    EARLE, JD
    DURR, ED
    KOZELSKY, TF
    WIEAND, HS
    OESTERLING, JE
    JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (11) : 2158 - 2166
  • [38] Urinary obstruction following stereotactic body radiation therapy (SBRT) for clinically localized prostate cancer
    Arscott, W. Tristram
    Chen, Leonard
    Wilson, Nathan
    Bhagat, Aditi
    Kim, Joy S.
    Yung, Thomas M.
    Lei, Siyuan
    Collins, Brian Timothy
    Suy, Simeng
    Dritschilo, Anatoly
    Lynch, John H.
    Collins, Sean P.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (04)
  • [39] Mean time to cancer-specific death of apparently clinically localized prostate cancer: policy implications for threshold ages in prostate-specific antigen screening and ablative therapy
    Horan, AH
    McGehee, M
    BJU INTERNATIONAL, 2000, 85 (09) : 1063 - 1066
  • [40] Prostate Cancer-Specific Mortality and Survival Outcomes for Salvage Radiation Therapy After Radical Prostatectomy
    Agrawal, S.
    Stephenson, A. J.
    Michalski, J.
    Efstathiou, J. A.
    Pisansky, T. M.
    Feng, F.
    Hamstra, D. A.
    Koontz, B. F.
    Liauw, S.
    Abramowitz, M. C.
    Pollack, A.
    Anscher, M. S.
    Moghanaki, D.
    Den, R. B.
    Stephans, K. L.
    Gao, T.
    Kattan, M.
    Tendulkar, R. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2016, 96 (02): : S101 - S101